English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 16 December 2014, 19:40 HKT/SGT
Share:
    

Source: China Pioneer Pharma Holdings Limited
China Pioneer Pharma Joins Hand with NovaBay Pharmaceuticals and the NNFF To Offer Free New Life-Saving Treatment for "Flesh-Eating" Disease

HONG KONG, Dec 16, 2014 - (ACN Newswire) - China Pioneer Pharma Holdings Limited announces that, as the exclusive marketer, promotor and distributor for skin and wound cleanser NeutroPhase in mainland China and parts of Southeast Asia, the Group will offer the life- and limb-saving product, NeutroPhase, and relevant medical guidance at no charge to patients who suffer from flesh-eating disease in the region to tie in with the agreement signed between the product manufacturer - NovaBay Pharmaceuticals, Inc. and the National Necrotizing Fasciitis Foundation (NNFF) in the United States. This will enable doctors to save life of patients as quick as possible--- and to curb the deterioration of the situation to avoid the need for amputation.

NeutroPhase, which has been fully tested, was pioneered by Seton Medical Center in California, United States. Among the flesh-eating disease patients that are in use of NeutroPhase , all the patients have recovered and there are no need for them to undertake amputation. NeutroPhase does not only kill bacteria, but also neutralizes the toxins produced by both bacteria and the immune system, stopping the spread of dead tissue and saving body parts from amputation. The treatment has been featured in journals like WOUNDS and other American newspaper articles. Other physicians have successfully used NeutroPhase to treat victims who suffer from flesh-eating disease reflecting fully the positive medical effectof NeutroPhase.

Mr. LI Xinzhou, Chairman, Executive Director and Chief Executive Officer of China Pioneer Pharma said: "The new treatment is especially important now because of the growing threat of flesh-eating disease caused by bacteria that have become resistant to regular antibiotics. We will cooperate together with NovaBay toprovide free NeutroPhase with step-by-step guidance to promote the new treatment. We strongly believe that NeutroPhase can bring a major improvement to the world's medical care industry and will satisfy the enormous medical needs."

Topic: Press release summary
Source: China Pioneer Pharma Holdings Limited

Sectors: Daily Finance, Daily News, BioTech, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

China Pioneer Pharma Holdings Limited Related News
Mar 30, 2016 12:54 HKT/SGT
中國先鋒醫藥公佈2015年全年業績
Mar 30, 2016 12:52 HKT/SGT
China Pioneer Pharma Announces Annual Results for Year Ended 31 December 2015
Mar 10, 2016 18:00 HKT/SGT
UNITY Balloon Expandable Bioresorbable Hybrid Biliary/Peripheral Vascular Stent Implanted for the 1st Time in Southeast Asia; China Pioneer Pharma is the Distributor
Feb 25, 2016 11:56 HKT/SGT
中國先鋒醫藥重要產品普利莫營銷、推廣及銷售權擴大至全國
Feb 25, 2016 11:52 HKT/SGT
China Pioneer Pharma Extended the Rights to Market, Promote and Sell Polimod in China
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575